Sort
16,300 grants matching “fatty liver disease”
Nicotine and Alcoholic Liver Disease
$354,429Yongke Lu · East Tennessee State University · R01 · FY2016 · AA
MECHANISMS FOR FETAL HEPATIC PROGRAMMING IN THE NON-HUMAN PRIMATE (NHP)
$354,426Jacob E Friedman · University Of Colorado Denver · R01 · FY2008 · DK
Hypo-Lipidemic Actions of Creosote Bush-Derived NDGA
$354,420Salman Azhar · Palo Alto Veterans Instit For Research · R01 · FY2012 · HL
Pyruvate dehydrogenase encephalopathy: mechanisms and therapy
$354,375Juan M. Pascual · Ut Southwestern Medical Center · R01 · FY2017 · NS
Pyruvate dehydrogenase encephalopathy: mechanisms and therapy
$354,375Juan M. Pascual · Ut Southwestern Medical Center · R01 · FY2019 · NS
Pyruvate dehydrogenase encephalopathy: mechanisms and therapy
$354,375Juan M. Pascual · Ut Southwestern Medical Center · R01 · FY2020 · NS
Pyruvate dehydrogenase encephalopathy: mechanisms and therapy
$354,375Juan M. Pascual · Ut Southwestern Medical Center · R01 · FY2021 · NS
Fatty Liver Preventive Effects and High Dose Hepatotoxicity of Tea Polyphenols
$354,276Joshua D Lambert · Pennsylvania State University, The · R01 · FY2010 · AT
Biomarker Discovery for Nonalcoholic Fatty Liver Disease in Children
$354,252Miriam B. Vos · Emory University · R01 · FY2020 · DK
Adipose Tissue Macrophage Phenotype and Function
$354,216Anthony W Ferrante · Columbia University Health Sciences · R01 · FY2010 · DK
Mechanisms and metabolic implications of LRP130 in NAFLD
$354,210Marcus P Cooper · Univ Of Massachusetts Med Sch Worcester · R01 · FY2012 · DK
Mechanisms and metabolic implications of LRP130 in NAFLD
$354,210Marcus P Cooper · Univ Of Massachusetts Med Sch Worcester · R01 · FY2014 · DK
Mechanisms and metabolic implications of LRP130 in NAFLD
$354,210Marcus P Cooper · Univ Of Massachusetts Med Sch Worcester · R01 · FY2011 · DK
Sparstolonin B as a TLR antagonist in suppression of liver inflammation through e
$354,136Daping Fan · University Of South Carolina At Columbia · P01 · FY2016 · AT
Lifespan Extension Despite Greatly Elevated Insulin and Body Fat
$354,092David E Harrison · Jackson Laboratory · R01 · FY2011 · AG
Lifespan Extension Despite Greatly Elevated Insulin and Body Fat
$354,092David E Harrison · Jackson Laboratory · R01 · FY2014 · AG
Lifespan Extension Despite Greatly Elevated Insulin and Body Fat
$354,092David E Harrison · Jackson Laboratory · R01 · FY2012 · AG
Mitochondrial Diabetes & Manganic Porphyrin Treatment
$354,082Douglas C Wallace · University Of California-Irvine · R01 · FY2008 · DK
Mitochondrial Diabetes & Manganic Porphyrin Treatment
$354,082Douglas C Wallace · University Of California-Irvine · R01 · FY2009 · DK
Estrogen receptors and Metabolic Features of PCOS
$354,046Andrea Dunaif · Northwestern University At Chicago · P50 · FY2013 · HD
Immune regulation of adipose tissue mass
$353,958Anthony W Ferrante · Columbia University Health Sciences · R01 · FY2016 · DK
Novel Therapies in alcoholic hepatitis - UMMS Translational Program
$353,929Gyongyi Szabo · Univ Of Massachusetts Med Sch Worcester · U01 · FY2017 · AA
Novel Therapies in alcoholic hepatitis - UMMS Translational Program
$353,929Gyongyi Szabo · Univ Of Massachusetts Med Sch Worcester · U01 · FY2016 · AA
Stress Signaling Pathways in Toxicity and Disease
$353,926Michael Karin · University Of California, San Diego · R01 · FY2009 · ES
Stress Signaling Pathways in Toxicity and Disease
$353,922Michael Karin · University Of California, San Diego · R01 · FY2008 · ES